Beneficial	O
Effects	O
of	O
Phyllanthus	B:C0950041
amarus	I:C0950041
Against	O
High	O
Fructose	I:C0012155
Diet	I:C0012155
Induced	O
Insulin	O
Resistance	I:C0021655
and	O
Hepatic	O
Oxidative	I:C0242606
Stress	I:C0242606
in	O
Male	O
Wistar	O
Rats	I:C0034716
.	O

Beneficial	O
Effects	O
of	O
Phyllanthus	O
amarus	I:C0950041
Against	O
High	B:C0012155
Fructose	I:C0012155
Diet	I:C0012155
Induced	O
Insulin	O
Resistance	I:C0021655
and	O
Hepatic	O
Oxidative	I:C0242606
Stress	I:C0242606
in	O
Male	O
Wistar	O
Rats	I:C0034716
.	O

Beneficial	O
Effects	O
of	O
Phyllanthus	O
amarus	I:C0950041
Against	O
High	O
Fructose	I:C0012155
Diet	I:C0012155
Induced	O
Insulin	B:C0021655
Resistance	I:C0021655
and	O
Hepatic	O
Oxidative	I:C0242606
Stress	I:C0242606
in	O
Male	O
Wistar	O
Rats	I:C0034716
.	O

Beneficial	O
Effects	O
of	O
Phyllanthus	O
amarus	I:C0950041
Against	O
High	O
Fructose	I:C0012155
Diet	I:C0012155
Induced	O
Insulin	O
Resistance	I:C0021655
and	O
Hepatic	B:C0242606
Oxidative	I:C0242606
Stress	I:C0242606
in	O
Male	O
Wistar	O
Rats	I:C0034716
.	O

Beneficial	O
Effects	O
of	O
Phyllanthus	O
amarus	I:C0950041
Against	O
High	O
Fructose	I:C0012155
Diet	I:C0012155
Induced	O
Insulin	O
Resistance	I:C0021655
and	O
Hepatic	O
Oxidative	I:C0242606
Stress	I:C0242606
in	O
Male	O
Wistar	B:C0034716
Rats	I:C0034716
.	O

Insulin	B:C0021655
resistance	I:C0021655
(	O
Insulin	O
resistance	I:C0021655
)	O
is	O
a	O
characteristic	O
feature	O
of	O
obesity	O
,	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
,	O
and	O
cardiovascular	O
diseases	I:C0007222
.	O

Insulin	O
resistance	I:C0021655
(	O
Insulin	B:C0021655
resistance	I:C0021655
)	O
is	O
a	O
characteristic	O
feature	O
of	O
obesity	O
,	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
,	O
and	O
cardiovascular	O
diseases	I:C0007222
.	O

Insulin	O
resistance	I:C0021655
(	O
Insulin	O
resistance	I:C0021655
)	O
is	O
a	O
characteristic	O
feature	O
of	O
obesity	B:C0028754
,	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
,	O
and	O
cardiovascular	O
diseases	I:C0007222
.	O

Insulin	O
resistance	I:C0021655
(	O
Insulin	O
resistance	I:C0021655
)	O
is	O
a	O
characteristic	O
feature	O
of	O
obesity	O
,	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
,	O
and	O
cardiovascular	O
diseases	I:C0007222
.	O

Insulin	O
resistance	I:C0021655
(	O
Insulin	O
resistance	I:C0021655
)	O
is	O
a	O
characteristic	O
feature	O
of	O
obesity	O
,	O
type	O
2	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
,	O
and	O
cardiovascular	B:C0007222
diseases	I:C0007222
.	O

Emerging	O
evidence	O
suggests	O
that	O
the	O
high	B:C0016745
-	I:C0016745
fructose	I:C0016745
consumption	O
is	O
a	O
potential	O
and	O
important	O
factor	O
responsible	O
for	O
the	O
rising	O
incidence	O
of	O
Insulin	O
resistance	I:C0021655
.	O

Emerging	O
evidence	O
suggests	O
that	O
the	O
high	O
-	I:C0016745
fructose	I:C0016745
consumption	B:C1947907
is	O
a	O
potential	O
and	O
important	O
factor	O
responsible	O
for	O
the	O
rising	O
incidence	O
of	O
Insulin	O
resistance	I:C0021655
.	O

Emerging	O
evidence	O
suggests	O
that	O
the	O
high	O
-	I:C0016745
fructose	I:C0016745
consumption	O
is	O
a	O
potential	O
and	O
important	O
factor	O
responsible	O
for	O
the	O
rising	O
incidence	O
of	O
Insulin	B:C0021655
resistance	I:C0021655
.	O

The	O
present	O
study	B:C2603343
investigates	O
the	O
beneficial	O
effects	O
of	O
aqueous	O
extract	O
of	O
Phyllanthus	O
amaru	I:C0950041
s	O
(	O
PAAE	O
)	O
on	O
Insulin	O
resistance	I:C0021655
and	O
oxidative	O
stress	I:C0242606
in	O
high	O
-	I:C0016745
fructose	I:C0016745
(	O
high	O
-	I:C0016745
fructose	I:C0016745
)	O
fed	O
male	O
Wistar	O
rats	I:C0034716
.	O

The	O
present	O
study	O
investigates	O
the	O
beneficial	O
effects	O
of	O
aqueous	O
extract	O
of	O
Phyllanthus	B:C0950041
amaru	I:C0950041
s	O
(	O
PAAE	O
)	O
on	O
Insulin	O
resistance	I:C0021655
and	O
oxidative	O
stress	I:C0242606
in	O
high	O
-	I:C0016745
fructose	I:C0016745
(	O
high	O
-	I:C0016745
fructose	I:C0016745
)	O
fed	O
male	O
Wistar	O
rats	I:C0034716
.	O

The	O
present	O
study	O
investigates	O
the	O
beneficial	O
effects	O
of	O
aqueous	O
extract	O
of	O
Phyllanthus	O
amaru	I:C0950041
s	O
(	O
PAAE	O
)	O
on	O
Insulin	B:C0021655
resistance	I:C0021655
and	O
oxidative	O
stress	I:C0242606
in	O
high	O
-	I:C0016745
fructose	I:C0016745
(	O
high	O
-	I:C0016745
fructose	I:C0016745
)	O
fed	O
male	O
Wistar	O
rats	I:C0034716
.	O

The	O
present	O
study	O
investigates	O
the	O
beneficial	O
effects	O
of	O
aqueous	O
extract	O
of	O
Phyllanthus	O
amaru	I:C0950041
s	O
(	O
PAAE	O
)	O
on	O
Insulin	O
resistance	I:C0021655
and	O
oxidative	B:C0242606
stress	I:C0242606
in	O
high	O
-	I:C0016745
fructose	I:C0016745
(	O
high	O
-	I:C0016745
fructose	I:C0016745
)	O
fed	O
male	O
Wistar	O
rats	I:C0034716
.	O

The	O
present	O
study	O
investigates	O
the	O
beneficial	O
effects	O
of	O
aqueous	O
extract	O
of	O
Phyllanthus	O
amaru	I:C0950041
s	O
(	O
PAAE	O
)	O
on	O
Insulin	O
resistance	I:C0021655
and	O
oxidative	O
stress	I:C0242606
in	O
high	B:C0016745
-	I:C0016745
fructose	I:C0016745
(	O
high	O
-	I:C0016745
fructose	I:C0016745
)	O
fed	O
male	O
Wistar	O
rats	I:C0034716
.	O

The	O
present	O
study	O
investigates	O
the	O
beneficial	O
effects	O
of	O
aqueous	O
extract	O
of	O
Phyllanthus	O
amaru	I:C0950041
s	O
(	O
PAAE	O
)	O
on	O
Insulin	O
resistance	I:C0021655
and	O
oxidative	O
stress	I:C0242606
in	O
high	O
-	I:C0016745
fructose	I:C0016745
(	O
high	B:C0016745
-	I:C0016745
fructose	I:C0016745
)	O
fed	O
male	O
Wistar	O
rats	I:C0034716
.	O

The	O
present	O
study	O
investigates	O
the	O
beneficial	O
effects	O
of	O
aqueous	O
extract	O
of	O
Phyllanthus	O
amaru	I:C0950041
s	O
(	O
PAAE	O
)	O
on	O
Insulin	O
resistance	I:C0021655
and	O
oxidative	O
stress	I:C0242606
in	O
high	O
-	I:C0016745
fructose	I:C0016745
(	O
high	O
-	I:C0016745
fructose	I:C0016745
)	O
fed	O
male	O
Wistar	B:C0034716
rats	I:C0034716
.	O

HF	B:C0012155
diet	I:C0012155
(	O
66	O
%	O
of	O
fructose	O
)	O
and	O
PAAE	O
(	O
200	O
mg	O
/	O
kg	O
body	O
weight	O
/	O
day	O
)	O
were	O
given	O
concurrently	O
to	O
the	O
rats	O
for	O
a	O
period	O
of	O
60	O
days	O
.	O

HF	O
diet	I:C0012155
(	O
66	O
%	O
of	O
fructose	O
)	O
and	O
PAAE	O
(	O
200	O
mg	O
/	O
kg	O
body	O
weight	O
/	O
day	O
)	O
were	O
given	O
concurrently	O
to	O
the	O
rats	B:C0034716
for	O
a	O
period	O
of	O
60	O
days	O
.	O

Fructose	O
-	O
fed	O
rats	B:C0034716
showed	O
weight	O
gain	I:C0043094
,	O
hyperglycemia	O
,	O
hyperinsulinemia	O
,	O
impaired	O
glucose	I:C0271650
tolerance	I:C0271650
,	O
impaired	O
insulin	I:C0920563
sensitivity	I:C0920563
,	O
dyslipidemia	O
,	O
hyperleptinemia	O
,	O
and	O
hypoadiponectinemia	O
(	O
P	O
<	O
0.05	O
)	O
after	O
60	O
days	O
.	O

Fructose	O
-	O
fed	O
rats	O
showed	O
weight	B:C0043094
gain	I:C0043094
,	O
hyperglycemia	O
,	O
hyperinsulinemia	O
,	O
impaired	O
glucose	I:C0271650
tolerance	I:C0271650
,	O
impaired	O
insulin	I:C0920563
sensitivity	I:C0920563
,	O
dyslipidemia	O
,	O
hyperleptinemia	O
,	O
and	O
hypoadiponectinemia	O
(	O
P	O
<	O
0.05	O
)	O
after	O
60	O
days	O
.	O

Fructose	O
-	O
fed	O
rats	O
showed	O
weight	O
gain	I:C0043094
,	O
hyperglycemia	B:C0020456
,	O
hyperinsulinemia	O
,	O
impaired	O
glucose	I:C0271650
tolerance	I:C0271650
,	O
impaired	O
insulin	I:C0920563
sensitivity	I:C0920563
,	O
dyslipidemia	O
,	O
hyperleptinemia	O
,	O
and	O
hypoadiponectinemia	O
(	O
P	O
<	O
0.05	O
)	O
after	O
60	O
days	O
.	O

Fructose	O
-	O
fed	O
rats	O
showed	O
weight	O
gain	I:C0043094
,	O
hyperglycemia	O
,	O
hyperinsulinemia	B:C0020459
,	O
impaired	O
glucose	I:C0271650
tolerance	I:C0271650
,	O
impaired	O
insulin	I:C0920563
sensitivity	I:C0920563
,	O
dyslipidemia	O
,	O
hyperleptinemia	O
,	O
and	O
hypoadiponectinemia	O
(	O
P	O
<	O
0.05	O
)	O
after	O
60	O
days	O
.	O

Fructose	O
-	O
fed	O
rats	O
showed	O
weight	O
gain	I:C0043094
,	O
hyperglycemia	O
,	O
hyperinsulinemia	O
,	O
impaired	B:C0271650
glucose	I:C0271650
tolerance	I:C0271650
,	O
impaired	O
insulin	I:C0920563
sensitivity	I:C0920563
,	O
dyslipidemia	O
,	O
hyperleptinemia	O
,	O
and	O
hypoadiponectinemia	O
(	O
P	O
<	O
0.05	O
)	O
after	O
60	O
days	O
.	O

Fructose	O
-	O
fed	O
rats	O
showed	O
weight	O
gain	I:C0043094
,	O
hyperglycemia	O
,	O
hyperinsulinemia	O
,	O
impaired	O
glucose	I:C0271650
tolerance	I:C0271650
,	O
impaired	B:C0920563
insulin	I:C0920563
sensitivity	I:C0920563
,	O
dyslipidemia	O
,	O
hyperleptinemia	O
,	O
and	O
hypoadiponectinemia	O
(	O
P	O
<	O
0.05	O
)	O
after	O
60	O
days	O
.	O

Fructose	O
-	O
fed	O
rats	O
showed	O
weight	O
gain	I:C0043094
,	O
hyperglycemia	O
,	O
hyperinsulinemia	O
,	O
impaired	O
glucose	I:C0271650
tolerance	I:C0271650
,	O
impaired	O
insulin	I:C0920563
sensitivity	I:C0920563
,	O
dyslipidemia	B:C0242339
,	O
hyperleptinemia	O
,	O
and	O
hypoadiponectinemia	O
(	O
P	O
<	O
0.05	O
)	O
after	O
60	O
days	O
.	O

Fructose	O
-	O
fed	O
rats	O
showed	O
weight	O
gain	I:C0043094
,	O
hyperglycemia	O
,	O
hyperinsulinemia	O
,	O
impaired	O
glucose	I:C0271650
tolerance	I:C0271650
,	O
impaired	O
insulin	I:C0920563
sensitivity	I:C0920563
,	O
dyslipidemia	O
,	O
hyperleptinemia	B:C0012634
,	O
and	O
hypoadiponectinemia	O
(	O
P	O
<	O
0.05	O
)	O
after	O
60	O
days	O
.	O

Fructose	O
-	O
fed	O
rats	O
showed	O
weight	O
gain	I:C0043094
,	O
hyperglycemia	O
,	O
hyperinsulinemia	O
,	O
impaired	O
glucose	I:C0271650
tolerance	I:C0271650
,	O
impaired	O
insulin	I:C0920563
sensitivity	I:C0920563
,	O
dyslipidemia	O
,	O
hyperleptinemia	O
,	O
and	O
hypoadiponectinemia	B:C2675519
(	O
P	O
<	O
0.05	O
)	O
after	O
60	O
days	O
.	O

Co-administration	B:C1533734
of	O
PAAE	O
along	O
with	O
HF	O
diet	I:C0012155
significantly	O
ameliorated	O
all	O
these	O
alterations	O
.	O

Co-administration	O
of	O
PAAE	O
along	O
with	O
HF	B:C0012155
diet	I:C0012155
significantly	O
ameliorated	O
all	O
these	O
alterations	O
.	O

Regarding	O
hepatic	B:C0205054
antioxidant	O
status	I:C1148564
,	O
higher	O
lipid	O
peroxidation	I:C0023775
and	O
protein	O
oxidation	I:C1159301
,	O
lower	O
reduced	O
glutathione	I:C0034917
levels	O
and	O
lower	O
activities	I:C3890174
of	O
enzymatic	O
antioxidants	I:C0003402
,	O
and	O
the	O
histopathological	O
changes	O
like	O
mild	O
to	O
severe	O
distortion	O
of	O
the	O
normal	O
architecture	O
as	O
well	O
as	O
the	O
prominence	O
and	O
widening	O
of	O
the	O
liver	O
sinusoids	I:C0227523
observed	O
in	O
the	O
HF	O
diet	I:C0012155
-	O
fed	O
rats	O
were	O
significantly	O
prevented	O
by	O
PAAE	O
treatment	O
.	O

Regarding	O
hepatic	O
antioxidant	B:C1148564
status	I:C1148564
,	O
higher	O
lipid	O
peroxidation	I:C0023775
and	O
protein	O
oxidation	I:C1159301
,	O
lower	O
reduced	O
glutathione	I:C0034917
levels	O
and	O
lower	O
activities	I:C3890174
of	O
enzymatic	O
antioxidants	I:C0003402
,	O
and	O
the	O
histopathological	O
changes	O
like	O
mild	O
to	O
severe	O
distortion	O
of	O
the	O
normal	O
architecture	O
as	O
well	O
as	O
the	O
prominence	O
and	O
widening	O
of	O
the	O
liver	O
sinusoids	I:C0227523
observed	O
in	O
the	O
HF	O
diet	I:C0012155
-	O
fed	O
rats	O
were	O
significantly	O
prevented	O
by	O
PAAE	O
treatment	O
.	O

Regarding	O
hepatic	O
antioxidant	O
status	I:C1148564
,	O
higher	O
lipid	B:C0023775
peroxidation	I:C0023775
and	O
protein	O
oxidation	I:C1159301
,	O
lower	O
reduced	O
glutathione	I:C0034917
levels	O
and	O
lower	O
activities	I:C3890174
of	O
enzymatic	O
antioxidants	I:C0003402
,	O
and	O
the	O
histopathological	O
changes	O
like	O
mild	O
to	O
severe	O
distortion	O
of	O
the	O
normal	O
architecture	O
as	O
well	O
as	O
the	O
prominence	O
and	O
widening	O
of	O
the	O
liver	O
sinusoids	I:C0227523
observed	O
in	O
the	O
HF	O
diet	I:C0012155
-	O
fed	O
rats	O
were	O
significantly	O
prevented	O
by	O
PAAE	O
treatment	O
.	O

Regarding	O
hepatic	O
antioxidant	O
status	I:C1148564
,	O
higher	O
lipid	O
peroxidation	I:C0023775
and	O
protein	B:C1159301
oxidation	I:C1159301
,	O
lower	O
reduced	O
glutathione	I:C0034917
levels	O
and	O
lower	O
activities	I:C3890174
of	O
enzymatic	O
antioxidants	I:C0003402
,	O
and	O
the	O
histopathological	O
changes	O
like	O
mild	O
to	O
severe	O
distortion	O
of	O
the	O
normal	O
architecture	O
as	O
well	O
as	O
the	O
prominence	O
and	O
widening	O
of	O
the	O
liver	O
sinusoids	I:C0227523
observed	O
in	O
the	O
HF	O
diet	I:C0012155
-	O
fed	O
rats	O
were	O
significantly	O
prevented	O
by	O
PAAE	O
treatment	O
.	O

Regarding	O
hepatic	O
antioxidant	O
status	I:C1148564
,	O
higher	O
lipid	O
peroxidation	I:C0023775
and	O
protein	O
oxidation	I:C1159301
,	O
lower	O
reduced	B:C0034917
glutathione	I:C0034917
levels	O
and	O
lower	O
activities	I:C3890174
of	O
enzymatic	O
antioxidants	I:C0003402
,	O
and	O
the	O
histopathological	O
changes	O
like	O
mild	O
to	O
severe	O
distortion	O
of	O
the	O
normal	O
architecture	O
as	O
well	O
as	O
the	O
prominence	O
and	O
widening	O
of	O
the	O
liver	O
sinusoids	I:C0227523
observed	O
in	O
the	O
HF	O
diet	I:C0012155
-	O
fed	O
rats	O
were	O
significantly	O
prevented	O
by	O
PAAE	O
treatment	O
.	O

Regarding	O
hepatic	O
antioxidant	O
status	I:C1148564
,	O
higher	O
lipid	O
peroxidation	I:C0023775
and	O
protein	O
oxidation	I:C1159301
,	O
lower	O
reduced	O
glutathione	I:C0034917
levels	O
and	O
lower	B:C3890174
activities	I:C3890174
of	O
enzymatic	O
antioxidants	I:C0003402
,	O
and	O
the	O
histopathological	O
changes	O
like	O
mild	O
to	O
severe	O
distortion	O
of	O
the	O
normal	O
architecture	O
as	O
well	O
as	O
the	O
prominence	O
and	O
widening	O
of	O
the	O
liver	O
sinusoids	I:C0227523
observed	O
in	O
the	O
HF	O
diet	I:C0012155
-	O
fed	O
rats	O
were	O
significantly	O
prevented	O
by	O
PAAE	O
treatment	O
.	O

Regarding	O
hepatic	O
antioxidant	O
status	I:C1148564
,	O
higher	O
lipid	O
peroxidation	I:C0023775
and	O
protein	O
oxidation	I:C1159301
,	O
lower	O
reduced	O
glutathione	I:C0034917
levels	O
and	O
lower	O
activities	I:C3890174
of	O
enzymatic	B:C0003402
antioxidants	I:C0003402
,	O
and	O
the	O
histopathological	O
changes	O
like	O
mild	O
to	O
severe	O
distortion	O
of	O
the	O
normal	O
architecture	O
as	O
well	O
as	O
the	O
prominence	O
and	O
widening	O
of	O
the	O
liver	O
sinusoids	I:C0227523
observed	O
in	O
the	O
HF	O
diet	I:C0012155
-	O
fed	O
rats	O
were	O
significantly	O
prevented	O
by	O
PAAE	O
treatment	O
.	O

Regarding	O
hepatic	O
antioxidant	O
status	I:C1148564
,	O
higher	O
lipid	O
peroxidation	I:C0023775
and	O
protein	O
oxidation	I:C1159301
,	O
lower	O
reduced	O
glutathione	I:C0034917
levels	O
and	O
lower	O
activities	I:C3890174
of	O
enzymatic	O
antioxidants	I:C0003402
,	O
and	O
the	O
histopathological	O
changes	O
like	O
mild	O
to	O
severe	O
distortion	O
of	O
the	O
normal	O
architecture	O
as	O
well	O
as	O
the	O
prominence	O
and	O
widening	O
of	O
the	O
liver	B:C0227523
sinusoids	I:C0227523
observed	O
in	O
the	O
HF	O
diet	I:C0012155
-	O
fed	O
rats	O
were	O
significantly	O
prevented	O
by	O
PAAE	O
treatment	O
.	O

Regarding	O
hepatic	O
antioxidant	O
status	I:C1148564
,	O
higher	O
lipid	O
peroxidation	I:C0023775
and	O
protein	O
oxidation	I:C1159301
,	O
lower	O
reduced	O
glutathione	I:C0034917
levels	O
and	O
lower	O
activities	I:C3890174
of	O
enzymatic	O
antioxidants	I:C0003402
,	O
and	O
the	O
histopathological	O
changes	O
like	O
mild	O
to	O
severe	O
distortion	O
of	O
the	O
normal	O
architecture	O
as	O
well	O
as	O
the	O
prominence	O
and	O
widening	O
of	O
the	O
liver	O
sinusoids	I:C0227523
observed	O
in	O
the	O
HF	B:C0012155
diet	I:C0012155
-	O
fed	O
rats	O
were	O
significantly	O
prevented	O
by	O
PAAE	O
treatment	O
.	O

Regarding	O
hepatic	O
antioxidant	O
status	I:C1148564
,	O
higher	O
lipid	O
peroxidation	I:C0023775
and	O
protein	O
oxidation	I:C1159301
,	O
lower	O
reduced	O
glutathione	I:C0034917
levels	O
and	O
lower	O
activities	I:C3890174
of	O
enzymatic	O
antioxidants	I:C0003402
,	O
and	O
the	O
histopathological	O
changes	O
like	O
mild	O
to	O
severe	O
distortion	O
of	O
the	O
normal	O
architecture	O
as	O
well	O
as	O
the	O
prominence	O
and	O
widening	O
of	O
the	O
liver	O
sinusoids	I:C0227523
observed	O
in	O
the	O
HF	O
diet	I:C0012155
-	O
fed	O
rats	B:C0034716
were	O
significantly	O
prevented	O
by	O
PAAE	O
treatment	O
.	O

Regarding	O
hepatic	O
antioxidant	O
status	I:C1148564
,	O
higher	O
lipid	O
peroxidation	I:C0023775
and	O
protein	O
oxidation	I:C1159301
,	O
lower	O
reduced	O
glutathione	I:C0034917
levels	O
and	O
lower	O
activities	I:C3890174
of	O
enzymatic	O
antioxidants	I:C0003402
,	O
and	O
the	O
histopathological	O
changes	O
like	O
mild	O
to	O
severe	O
distortion	O
of	O
the	O
normal	O
architecture	O
as	O
well	O
as	O
the	O
prominence	O
and	O
widening	O
of	O
the	O
liver	O
sinusoids	I:C0227523
observed	O
in	O
the	O
HF	O
diet	I:C0012155
-	O
fed	O
rats	O
were	O
significantly	O
prevented	O
by	O
PAAE	O
treatment	B:C0087111
.	O

These	O
findings	O
indicate	O
that	O
PAAE	O
is	O
beneficial	O
in	O
improving	O
insulin	B:C0920563
sensitivity	I:C0920563
and	O
attenuating	O
metabolic	O
syndrome	I:C0025517
and	O
hepatic	O
oxidative	I:C0242606
stress	I:C0242606
in	O
fructose	O
-	O
fed	O
rats	O
.	O

These	O
findings	O
indicate	O
that	O
PAAE	O
is	O
beneficial	O
in	O
improving	O
insulin	O
sensitivity	I:C0920563
and	O
attenuating	O
metabolic	B:C0025517
syndrome	I:C0025517
and	O
hepatic	O
oxidative	I:C0242606
stress	I:C0242606
in	O
fructose	O
-	O
fed	O
rats	O
.	O

These	O
findings	O
indicate	O
that	O
PAAE	O
is	O
beneficial	O
in	O
improving	O
insulin	O
sensitivity	I:C0920563
and	O
attenuating	O
metabolic	O
syndrome	I:C0025517
and	O
hepatic	B:C0242606
oxidative	I:C0242606
stress	I:C0242606
in	O
fructose	O
-	O
fed	O
rats	O
.	O

These	O
findings	O
indicate	O
that	O
PAAE	O
is	O
beneficial	O
in	O
improving	O
insulin	O
sensitivity	I:C0920563
and	O
attenuating	O
metabolic	O
syndrome	I:C0025517
and	O
hepatic	O
oxidative	I:C0242606
stress	I:C0242606
in	O
fructose	O
-	O
fed	O
rats	B:C0034716
.	O

